|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 16.62 EUR | -2.58% |
|
+0.48% | +8.63% |
| 01-06 | Frankfurt Stocks Close: DAX Rises to Just Below 25,000 Points | DP |
| 12-17 | SAF-HOLLAND : Warburg Research maintains a Buy rating | ZD |
| Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 3.87 | 5.46 | 5.56 | 7.17 | 6.16 | |||||
Return on Total Capital | 5.32 | 7.45 | 7.15 | 9.43 | 8.28 | |||||
Return On Equity % | 4.58 | 10.96 | 15.07 | 17.56 | 15.6 | |||||
Return on Common Equity | 4.58 | 11 | 15.07 | 17.5 | 15.52 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 19.19 | 17.39 | 16.92 | 19.8 | 22.17 | |||||
SG&A Margin | 11.62 | 9.48 | 8.63 | 9.66 | 11.53 | |||||
EBITDA Margin % | 9.69 | 9.62 | 9.39 | 11.31 | 12.37 | |||||
EBITA Margin % | 7.41 | 7.76 | 8.01 | 9.5 | 10.03 | |||||
EBIT Margin % | 6.13 | 6.78 | 7.14 | 8.58 | 8.86 | |||||
Income From Continuing Operations Margin % | 1.48 | 2.95 | 3.91 | 3.82 | 4.17 | |||||
Net Income Margin % | 1.44 | 2.95 | 3.9 | 3.8 | 4.12 | |||||
Net Avail. For Common Margin % | 1.44 | 2.95 | 3.9 | 3.8 | 4.12 | |||||
Normalized Net Income Margin | 3.12 | 3.86 | 4.02 | 4.16 | 4.16 | |||||
Levered Free Cash Flow Margin | 11.64 | -0.36 | 5.24 | 0.56 | 5.31 | |||||
Unlevered Free Cash Flow Margin | 12.2 | 0.02 | 5.79 | 1.61 | 6.58 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 1.01 | 1.29 | 1.25 | 1.34 | 1.11 | |||||
Fixed Assets Turnover | 4.95 | 6.48 | 8.54 | 8.83 | 5.36 | |||||
Receivables Turnover (Average Receivables) | 8.67 | 10.76 | 11.14 | 11.24 | 9.27 | |||||
Inventory Turnover (Average Inventory) | 5.26 | 6.43 | 6.56 | 6.64 | 4.88 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 2.48 | 2.37 | 1.85 | 2.26 | 1.68 | |||||
Quick Ratio | 1.66 | 1.45 | 1.22 | 1.36 | 0.98 | |||||
Operating Cash Flow to Current Liabilities | 0.81 | 0.18 | 0.45 | 0.55 | 0.39 | |||||
Days Sales Outstanding (Average Receivables) | 42.22 | 33.91 | 32.77 | 32.48 | 39.46 | |||||
Days Outstanding Inventory (Average Inventory) | 69.52 | 56.78 | 55.61 | 54.99 | 74.94 | |||||
Average Days Payable Outstanding | 54.26 | 42.07 | 42.51 | 39.45 | 52.41 | |||||
Cash Conversion Cycle (Average Days) | 57.47 | 48.62 | 45.87 | 48.03 | 61.99 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 124.81 | 99.73 | 174.34 | 149.28 | 149 | |||||
Total Debt / Total Capital | 55.52 | 49.93 | 63.55 | 59.88 | 59.84 | |||||
LT Debt/Equity | 119.25 | 91.06 | 146.1 | 140.67 | 104.71 | |||||
Long-Term Debt / Total Capital | 53.04 | 45.59 | 53.25 | 56.43 | 42.05 | |||||
Total Liabilities / Total Assets | 67.36 | 63.41 | 70.55 | 71.18 | 69.21 | |||||
EBIT / Interest Expense | 5.61 | 9.32 | 6.91 | 4.61 | 4.05 | |||||
EBITDA / Interest Expense | 9.77 | 14.17 | 9.61 | 6.44 | 6.12 | |||||
(EBITDA - Capex) / Interest Expense | 7.81 | 11.86 | 7.64 | 5.04 | 4.93 | |||||
Total Debt / EBITDA | 3.66 | 2.88 | 4.95 | 2.81 | 3.13 | |||||
Net Debt / EBITDA | 1.97 | 1.58 | 3.35 | 1.83 | 1.89 | |||||
Total Debt / (EBITDA - Capex) | 4.58 | 3.44 | 6.23 | 3.59 | 3.88 | |||||
Net Debt / (EBITDA - Capex) | 2.47 | 1.89 | 4.22 | 2.34 | 2.34 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | -25.28 | 29.92 | 25.55 | 34.57 | -10.89 | |||||
Gross Profit, 1 Yr. Growth % | -14.52 | 21.56 | 23.11 | 58.27 | -0.25 | |||||
EBITDA, 1 Yr. Growth % | -8.01 | 37.44 | 24.42 | 62.2 | -2.04 | |||||
EBITA, 1 Yr. Growth % | -11.24 | 47.91 | 32.19 | 59.44 | -5.31 | |||||
EBIT, 1 Yr. Growth % | -14.25 | 59.29 | 35.18 | 61.67 | -7.38 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | 37.67 | 159.57 | 66.4 | 31.51 | -2.85 | |||||
Net Income, 1 Yr. Growth % | 53.64 | 166.31 | 66.27 | 30.86 | -3.23 | |||||
Normalized Net Income, 1 Yr. Growth % | -17.77 | 82.6 | 33.81 | 39.25 | -10.15 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | 58.84 | 169.76 | 66.27 | 30.8 | -3.41 | |||||
Accounts Receivable, 1 Yr. Growth % | -24.33 | 42.91 | 6.23 | 51.19 | -15.82 | |||||
Inventory, 1 Yr. Growth % | -24.81 | 53.43 | 4.27 | 51.64 | -4.96 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 1.66 | -2.97 | -6.61 | 69.72 | 3.93 | |||||
Total Assets, 1 Yr. Growth % | -6 | 10.19 | 47.73 | 10.23 | 2.99 | |||||
Tangible Book Value, 1 Yr. Growth % | 10.04 | 105.58 | 52.27 | -66.36 | 47.97 | |||||
Common Equity, 1 Yr. Growth % | -2.35 | 24.31 | 18.99 | 7.38 | 10.66 | |||||
Cash From Operations, 1 Yr. Growth % | 52.32 | -71.25 | 286.86 | 32.16 | -1.02 | |||||
Capital Expenditures, 1 Yr. Growth % | -55.04 | 1.96 | 52.56 | 72.14 | -11.64 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | 164.99 | -104.16 | -1.17K | -85.58 | 556.99 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | 147.25 | -99.8 | -3.15K | -62.62 | 231.92 | |||||
Dividend Per Share, 1 Yr. Growth % | - | - | 71.43 | 41.67 | 0 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | -14.11 | -1.47 | 27.72 | 29.98 | 9.5 | |||||
Gross Profit, 2 Yr. CAGR % | -4.85 | 0.31 | 21.86 | 39.27 | 25.65 | |||||
EBITDA, 2 Yr. CAGR % | -6.23 | 8.91 | 29.78 | 42.06 | 25.72 | |||||
EBITA, 2 Yr. CAGR % | -9.92 | 9.85 | 38.51 | 45.18 | 22.48 | |||||
EBIT, 2 Yr. CAGR % | -13.22 | 11.01 | 45.2 | 47.83 | 21.94 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | -45.72 | 89.04 | 107.82 | 47.93 | 13.03 | |||||
Net Income, 2 Yr. CAGR % | -46.47 | 102.27 | 110.42 | 47.51 | 12.53 | |||||
Normalized Net Income, 2 Yr. CAGR % | -16.05 | 14.95 | 54.51 | 36.5 | 11.35 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | -42.84 | 107 | 111.78 | 47.47 | 12.4 | |||||
Accounts Receivable, 2 Yr. CAGR % | -17.14 | 3.99 | 23.21 | 28.68 | 11.33 | |||||
Inventory, 2 Yr. CAGR % | -16.05 | 7.41 | 26.48 | 25.74 | 20.05 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 16.08 | -0.68 | -4.81 | 25.9 | 42.09 | |||||
Total Assets, 2 Yr. CAGR % | -2.96 | 1.77 | 27.59 | 27.61 | 6.89 | |||||
Tangible Book Value, 2 Yr. CAGR % | 11.3 | 50.4 | 76.93 | -28.43 | -29.45 | |||||
Common Equity, 2 Yr. CAGR % | -1.51 | 10.18 | 21.62 | 13.04 | 9.01 | |||||
Cash From Operations, 2 Yr. CAGR % | 83.9 | -33.83 | 5.46 | 126.11 | 14.37 | |||||
Capital Expenditures, 2 Yr. CAGR % | -21.66 | -32.29 | 24.72 | 62.06 | 23.33 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 264.67 | -67.34 | -12.88 | 24.01 | 10.19 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 685.3 | -93.01 | -10.67 | 237.84 | 16.74 | |||||
Dividend Per Share, 2 Yr. CAGR % | - | - | - | 55.84 | 19.02 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | -5.55 | -1.4 | 6.82 | 29.96 | 14.61 | |||||
Gross Profit, 3 Yr. CAGR % | -5.2 | 2.14 | 7.12 | 32.75 | 24.61 | |||||
EBITDA, 3 Yr. CAGR % | -4.35 | 4.27 | 13.27 | 39.79 | 25.29 | |||||
EBITA, 3 Yr. CAGR % | -7.45 | 3.33 | 16.11 | 45.16 | 25.64 | |||||
EBIT, 3 Yr. CAGR % | -10.74 | 2.67 | 17.71 | 50.49 | 26.2 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | -29.79 | -8.55 | 81.17 | 78.42 | 28.58 | |||||
Net Income, 3 Yr. CAGR % | -31.48 | -8.62 | 89.48 | 79.61 | 28.17 | |||||
Normalized Net Income, 3 Yr. CAGR % | -12.67 | 4.23 | 19.99 | 49.25 | 18.38 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | -28.53 | -4.12 | 92.42 | 80.36 | 28.07 | |||||
Accounts Receivable, 3 Yr. CAGR % | -11.09 | -0.63 | 4.73 | 33.26 | 10.73 | |||||
Inventory, 3 Yr. CAGR % | -1.86 | 2.64 | 6.35 | 34.37 | 14.54 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 14.37 | 9.34 | -2.7 | 15.43 | 23.54 | |||||
Total Assets, 3 Yr. CAGR % | -2.66 | 1.24 | 15.23 | 21.52 | 19.06 | |||||
Tangible Book Value, 3 Yr. CAGR % | -14.94 | 36.56 | 51.02 | 1.74 | -8.82 | |||||
Common Equity, 3 Yr. CAGR % | -0.11 | 6.44 | 13.04 | 16.68 | 12.24 | |||||
Cash From Operations, 3 Yr. CAGR % | 34.45 | -0.93 | 19.21 | 13.7 | 71.68 | |||||
Capital Expenditures, 3 Yr. CAGR % | -1.97 | -14.47 | -11.23 | 38.86 | 32.39 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 60.27 | -18.81 | 24.86 | -52.17 | 134.82 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 48.26 | -50.44 | 24.13 | -33.18 | 246.53 | |||||
Dividend Per Share, 3 Yr. CAGR % | - | -8.04 | - | - | 34.42 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | -1.99 | 3.65 | 6.56 | 10.12 | 7.88 | |||||
Gross Profit, 5 Yr. CAGR % | -2.26 | 0.86 | 4.14 | 15.45 | 14.07 | |||||
EBITDA, 5 Yr. CAGR % | -2.11 | 2.18 | 6.7 | 17.64 | 18.1 | |||||
EBITA, 5 Yr. CAGR % | -4.57 | 0.85 | 6.93 | 17.94 | 18.62 | |||||
EBIT, 5 Yr. CAGR % | -6.49 | -0.29 | 6.23 | 18.29 | 19.39 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | -22.8 | -3.27 | 8.37 | 10.85 | 50.01 | |||||
Net Income, 5 Yr. CAGR % | -23.2 | -3.65 | 7.33 | 10.67 | 53.83 | |||||
Normalized Net Income, 5 Yr. CAGR % | -10.08 | 0.04 | 6.95 | 15.57 | 16.46 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | -21.21 | -0.94 | 10.37 | 13.9 | 55.19 | |||||
Accounts Receivable, 5 Yr. CAGR % | -3.93 | 3.15 | 1.3 | 10.19 | 7.98 | |||||
Inventory, 5 Yr. CAGR % | 1.39 | 8.44 | 8.62 | 11.32 | 11.63 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 9.48 | 6.53 | 6.27 | 15.69 | 13.21 | |||||
Total Assets, 5 Yr. CAGR % | 0.71 | 0 | 8.47 | 11.06 | 11.82 | |||||
Tangible Book Value, 5 Yr. CAGR % | -5.43 | 7.22 | 14.02 | 5.46 | 11.39 | |||||
Common Equity, 5 Yr. CAGR % | 0.83 | 4.27 | 8.07 | 9.03 | 11.41 | |||||
Cash From Operations, 5 Yr. CAGR % | 16.93 | -15.62 | 22 | 37.81 | 17.25 | |||||
Capital Expenditures, 5 Yr. CAGR % | -1.55 | 1.6 | 7.94 | 10.44 | 1.25 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 31.81 | -39.21 | 24.77 | 7.09 | 18.77 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 28.71 | -67.21 | 20.31 | 77.93 | 21.12 | |||||
Dividend Per Share, 5 Yr. CAGR % | - | -4.47 | 5.92 | 13.56 | - |
- Stock Market
- Equities
- SFQ Stock
- Financials SAF-Holland SE
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















